Toll Free: 1-888-928-9744

Aptalis Pharma Inc. - Product Pipeline Review - 2014

Published: Feb, 2014 | Pages: 29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Aptalis Pharma Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Aptalis Pharma Inc. - Product Pipeline Review - 2014', provides an overview of the Aptalis Pharma Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aptalis Pharma Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Aptalis Pharma Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Aptalis Pharma Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Aptalis Pharma Inc.'s pipeline products

Reasons to buy

- Evaluate Aptalis Pharma Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Aptalis Pharma Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Aptalis Pharma Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Aptalis Pharma Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aptalis Pharma Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Aptalis Pharma Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Aptalis Pharma Inc. Snapshot 4
Aptalis Pharma Inc. Overview 4
Key Information 4
Key Facts 4
Aptalis Pharma Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Aptalis Pharma Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Aptalis Pharma Inc. - Pipeline Products Glance 9
Aptalis Pharma Inc. - Late Stage Pipeline Products 9
Pre-Registration Products/Combination Treatment Modalities 9
Phase III Products/Combination Treatment Modalities 10
Aptalis Pharma Inc. - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Aptalis Pharma Inc. - Drug Profiles 12
levofloxacin 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
pancrelipase DR 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
EUR-1100 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Aptalis Pharma Inc. - Pipeline Analysis 16
Aptalis Pharma Inc. - Pipeline Products by Target 16
Aptalis Pharma Inc. - Pipeline Products by Route of Administration 17
Aptalis Pharma Inc. - Pipeline Products by Molecule Type 18
Aptalis Pharma Inc. - Pipeline Products by Mechanism of Action 19
Aptalis Pharma Inc. - Recent Pipeline Updates 20
Aptalis Pharma Inc. - Dormant Projects 23
Aptalis Pharma Inc. - Discontinued Pipeline Products 24
Discontinued Pipeline Product Profiles 24
itopride 24
Aptalis Pharma Inc. - Company Statement 25
Aptalis Pharma Inc. - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29
List of Tables
Aptalis Pharma Inc., Key Information 4
Aptalis Pharma Inc., Key Facts 4
Aptalis Pharma Inc. - Pipeline by Indication, 2014 6
Aptalis Pharma Inc. - Pipeline by Stage of Development, 2014 7
Aptalis Pharma Inc. - Monotherapy Products in Pipeline, 2014 8
Aptalis Pharma Inc. - Pre-Registration, 2014 9
Aptalis Pharma Inc. - Phase III, 2014 10
Aptalis Pharma Inc. - Phase I, 2014 11
Aptalis Pharma Inc. - Pipeline by Target, 2014 16
Aptalis Pharma Inc. - Pipeline by Route of Administration, 2014 17
Aptalis Pharma Inc. - Pipeline by Molecule Type, 2014 18
Aptalis Pharma Inc. - Pipeline Products by Mechanism of Action, 2014 19
Aptalis Pharma Inc. - Recent Pipeline Updates, 2014 20
Aptalis Pharma Inc. - Dormant Developmental Projects,2014 23
Aptalis Pharma Inc. - Discontinued Pipeline Products, 2014 24
Aptalis Pharma Inc., Other Locations 26
Aptalis Pharma Inc., Subsidiaries 27 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify